This HTML5 document contains 114 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n7http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q38966816
rdf:type
wikibase:Item
schema:description
scientific article published on 24 September 2016 vitskapeleg artikkel article scientifique 2016년 논문 wissenschaftlicher Artikel επιστημονικό άρθρο 2016年論文 2016年论文 videnskabelig artikel наукова стаття, опублікована у вересні 2016 מאמר מדעי 2016年論文 2016年论文 artykuł naukowy vetenskaplig artikel مقالة علمية نشرت في 24 سبتمبر 2016 artikull shkencor научни чланак articolo scientifico vědecký článek artigo científico teaduslik artikkel научная статья tudományos cikk article scientific scientific article published on 24 September 2016 2016年论文 2016年論文 naučni članak ২৪ সেপ্টেম্বর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2016年論文 2016年论文 bài báo khoa học tieteellinen artikkeli artigo científico article científic artículo científico publicado en 2016 мақолаи илмӣ научни чланак 2016 nî lūn-bûn scienca artikolo artikel ilmiah სამეცნიერო სტატია научна статия wetenschappelijk artikel vedecký článok vitenskapelig artikkel 2016年論文 scientific article published on 24 September 2016 2016年论文 bilimsel makale 2016年论文 artikulong pang-agham articol științific 2016年の論文 artículu científicu espublizáu en 2016 artigo científico บทความทางวิทยาศาสตร์
p:P577
wds:Q38966816-0631B4C3-7562-4025-94D6-2D196389A0B8
wdt:P577
2016-09-24T00:00:00Z
p:P2093
wds:Q38966816-29ECC646-6365-4D6A-A80F-CB8A80A7DA61 wds:Q38966816-30E476B9-42FD-4CCF-B9E3-508D6013C762 wds:Q38966816-70C7A125-3B87-44F8-AC88-8C670BB5A66B wds:Q38966816-4B2DC6A4-E976-4EE3-BFF7-05EA77001E37 wds:Q38966816-03B1B3BA-7724-40CF-91B0-2DBBB4B884AA wds:Q38966816-14C1C0D9-0F70-4E18-9A20-43497E1953AD wds:Q38966816-1F359012-A43B-4CC9-AA86-AC0200E6DBED wds:Q38966816-0BD9159B-B101-4128-B406-2A1FC56FA30C
wdt:P2093
Sergio Bracarda Claudia Weiss Pablo Maroto Vincent Molinie Paul Nathan Sylvie Negrier Viktor Grünwald Camillo Porta
rdfs:label
Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis
skos:prefLabel
Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis
schema:name
Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis
p:P50
wds:Q38966816-701E19F4-4C6E-4563-8BC8-B892C81075F1 wds:Q38966816-792E57D8-6484-4D8D-9647-F9A3CC6D39E4 wds:Q38966816-FB9ABC38-40EB-4435-B949-156DFD0FCC7F
wdt:P50
wd:Q54553923 wd:Q9188497 wd:Q54553347
p:P1476
wds:Q38966816-A6E7B62C-541C-46D5-9BB7-9AA0DC13C7D5
wdt:P1476
Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis
p:P304
wds:Q38966816-35B5A36F-92F4-46F3-B0BA-3624F8ECCBF8
wdt:P304
226-235
p:P31
wds:Q38966816-0177297D-9CE1-4E39-ACFC-BBD7E02369EC
wdt:P31
wd:Q13442814
p:P921
wds:Q38966816-03BEA6F8-B167-4AC9-A11E-3A86011E7BAD wds:Q38966816-34C494EC-B9DD-4B2D-9043-73E46A704E71 wds:Q38966816-846E2007-998C-4C9C-BDB7-8F8955D90FFD
wdt:P921
wd:Q1164529 wd:Q19000948 wd:Q42824440
p:P698
wds:Q38966816-EAD1E1E1-B58E-459E-ABDE-56C47E072467
wdtn:P698
n12:27680407
wdt:P698
27680407
p:P1433
wds:Q38966816-D96C40A5-684C-47D2-904B-DB203E524232
wdt:P1433
wd:Q332260
p:P478
wds:Q38966816-818D7945-EE30-41FF-90ED-B1CC8DEE1D6A
wdt:P478
69
p:P356
wds:Q38966816-8B521F97-9A1B-434A-916B-ECE3DA93D4F9
wdtn:P356
n7:J.EJCA.2016.08.004
wdt:P356
10.1016/J.EJCA.2016.08.004